Emerging Trends in Cancer Research provides a comprehensive and up-to-date exploration of the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes. Each chapter delves into the specific aspects of different cancers, offering insights into drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments. The book also addresses the importance of diagnostics and the evolving landscape of intellectual property in cancer treatment. Sections analyze cancer drug resistance mutations, biomarker trends, and diagnostics across various cancers, including intestinal, cardiac, brain, and blood cancers.
Readers will find coverage of clinical pipeline developments, intellectual property landscapes, and advancements in cancer therapeutics, diagnostics, and global drug delivery trends. This book is an invaluable resource for oncology, biomedical engineering, and pharmaceutical professionals, offering insights into the latest cancer research trends. It includes real-world case studies, practical applications, and discussions on regulatory and ethical considerations, making it essential for both seasoned researchers and graduate students.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. vii 7. About the editors - p. xiii 8. 1. Mapping cancer drug resistance mutations and mechanisms - p. 1 9. 2. Importance of diagnostics in cardiac cancer - p. 29 10. 3. Brain cancer—preclinical models - p. 53 11. 4. Advances in liver cancer research - p. 77 12. 5. Lung cancer: IP landscape - p. 105 13. 6. Colorectal cancer clinical updates - p. 143 14. 7. Breast cancer: IP landscape - p. 161 15. 8. Prostate cancer drugs in clinical trials - p. 211 16. 9. Global trends and IP landscape focusing on drug delivery for oral cancer treatment - p. 235 17. 10. Sodium-linolenic channels in cancer diagnostics - p. 261 18. 11. Mitochondrial targeting in cancer therapeutics - p. 295 19. 12. Oral cancer: Microenvironment, diagnostics and therapy trends - p. 317 20. 13. Cancer vaccines : Current trends and future perspectives - p. 345 21. 14. mRNA trends in cancer therapeutics - p. 373 22. 15. Pediatric blood cancer therapeutics - p. 407 23. 16. Current research trends in blood cancer treatment - p. 427 24. 17. Colorectal cancer: Current diagnostics and treatment trends - p. 455 25. Index - p. 486
Emerging Trends in Cancer Research provides a comprehensive and up-to-date exploration of the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes. Each chapter delves into the specific aspects of different cancers, offering insights into drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments. The book also addresses the importance of diagnostics and the evolving landscape of intellectual property in cancer treatment. Sections analyze cancer drug resistance mutations, biomarker trends, and diagnostics across various cancers, including intestinal, cardiac, brain, and blood cancers.
Readers will find coverage of clinical pipeline developments, intellectual property landscapes, and advancements in cancer therapeutics, diagnostics, and global drug delivery trends. This book is an invaluable resource for oncology, biomedical engineering, and pharmaceutical professionals, offering insights into the latest cancer research trends. It includes real-world case studies, practical applications, and discussions on regulatory and ethical considerations, making it essential for both seasoned researchers and graduate students.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. vii 7. About the editors - p. xiii 8. 1. Mapping cancer drug resistance mutations and mechanisms - p. 1 9. 2. Importance of diagnostics in cardiac cancer - p. 29 10. 3. Brain cancer—preclinical models - p. 53 11. 4. Advances in liver cancer research - p. 77 12. 5. Lung cancer: IP landscape - p. 105 13. 6. Colorectal cancer clinical updates - p. 143 14. 7. Breast cancer: IP landscape - p. 161 15. 8. Prostate cancer drugs in clinical trials - p. 211 16. 9. Global trends and IP landscape focusing on drug delivery for oral cancer treatment - p. 235 17. 10. Sodium-linolenic channels in cancer diagnostics - p. 261 18. 11. Mitochondrial targeting in cancer therapeutics - p. 295 19. 12. Oral cancer: Microenvironment, diagnostics and therapy trends - p. 317 20. 13. Cancer vaccines : Current trends and future perspectives - p. 345 21. 14. mRNA trends in cancer therapeutics - p. 373 22. 15. Pediatric blood cancer therapeutics - p. 407 23. 16. Current research trends in blood cancer treatment - p. 427 24. 17. Colorectal cancer: Current diagnostics and treatment trends - p. 455 25. Index - p. 486